Oncology Biotech Challenges Rival's Cancer Testing Patent
A Swiss biotechnology company has denied infringing a rival's patents by providing a DNA capture kit and software program, arguing that its IP rights should be nixed because the inventions were...To view the full article, register now.
Already a subscriber? Click here to view full article